A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, ...

Expected readouts in diabetes, cancer and depression headline a series of study results that could help the biotechnology ...

An East Lancashire man has been part of a clinical trial for a new experimental drug for the most common form of bladder ...

As the new year begins, individuals looking to improve their health might consider participating in clinical trials, ...

A clinical trial manager emphasizes the importance of a phased approach to educating patients about complex protocols and ...

Tectonic's lead asset, TX45, is a long-acting Fc-relaxin fusion protein to treat group 2 pulmonary hypertension. Read why I'm ...

In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community ...

ArMaDa clinical trial is set to assess the safety and efficacy of unilateral subretinal administration of OCU410 in subjects with GA ...

This BCI technology breakthrough enables the patient to convert their thoughts into Chinese texts on computer for ...

Nevrargenics who are behind a drug which they believe not only stops the impact of MND but reverses the damage already done.

Luke Johnston, a 10-year-old diagnosed with Retinitis Pigmentosa, is losing his eyesight, prompting his friends and family to raise millions to fund a clinical trial for a potential cure.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/95.C_N2kNfW.js ...